MyAverix Finance
NS · Pharmaceuticals
Wanbury Ltd (WANBURY)
Pharmaceuticals & Biotechnology
Wanbury Ltd (WANBURY) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $9.80B, P/E ratio is 14.82, net margin is 6.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for WANBURY
Wanbury Ltd (WANBURY) — FAQ
What is Wanbury Ltd's market cap?
Wanbury Ltd (WANBURY) has a reported market cap of $9.80B (data as of 2026-07-10).
What is WANBURY's P/E ratio?
The price-to-earnings (P/E) ratio for Wanbury Ltd (WANBURY) is 14.82 (data as of 2026-07-10).
Does Wanbury Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Wanbury Ltd (WANBURY). Check the MyAverix Finance app for the latest dividend data.
What sector is Wanbury Ltd in?
Wanbury Ltd (WANBURY) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is WANBURY listed on?
WANBURY is listed on NS.
What is Wanbury Ltd's net margin?
Wanbury Ltd (WANBURY) reports a net margin of 6.8% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.